NFSG
CMMB

Newbridge Financial Services Group’s Chemomab Therapeutics CMMB Stock Holding History

Newbridge Financial Services Group’s Portfolio CMMB Stock Details CMMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-275
Closed -$985 – 1195
2023
Q3 		$985 Hold
275
– – ﹤0.01% 1159
2023
Q2 		$1.45K Hold
275
– – ﹤0.01% 1175
2023
Q1 		$1.75K Hold
275
– – ﹤0.01% 1214
2022
Q4 		$3.52K Hold
275
– – ﹤0.01% 1127
2022
Q3 		$3K Hold
275
– – ﹤0.01% 1117
2022
Q2 		$4K Hold
275
– – ﹤0.01% 1045
2022
Q1 		$5K Buy
+275
New +$5.42K ﹤0.01% 1090

Other funds holding CMMB

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return